[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100517095":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":18,"centralContacts":24,"locations":18,"responsibleParty":31,"collaborators":18,"id":35,"slug":36,"hasResults":37,"nctId":38,"briefTitle":39,"officialTitle":39,"acronym":40,"eligibilityCriteria":41,"healthyVolunteers":42,"sex":43,"minAge":44,"maxAge":45,"enrollmentInfo":46,"targetDuration":18,"studyType":49,"phases":50,"briefSummary":52,"conditions":53,"keywords":18,"overallStatus":55,"whyStopped":18,"lastUpdateSubmitDate":56,"lastUpdatePostDateStruct":57,"startDateStruct":60,"completionDateStruct":62,"leadSponsor":64,"locationsCount":18},{"fullName":5,"class":6},"Tri-Service General Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"cognitive behavioral therapy","EXPERIMENTAL","6 weeks cognitive-behavioral therapy for insomnia",[13],"Behavioral: cognitive behavioral therapy",{"label":15,"type":16,"description":17,"interventionNames":18},"treat as usual","NO_INTERVENTION","provide usual care",null,[20],{"type":21,"name":9,"description":22,"armGroupLabels":23,"otherNames":18},"BEHAVIORAL","6 weeks cognitive behavioral therapy",[9],[25],{"name":26,"role":27,"phone":28,"phoneExt":29,"email":30},"Yu-Mu Hsien, PhD","CONTACT","886-2-87923311","10552","tsghirb@ndmctsgh.edu.tw",{"type":32,"investigatorFullName":33,"investigatorTitle":34,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"PRINCIPAL_INVESTIGATOR","Wen-Chii Tzeng","Professor","100517095","effects-of-cognitive-behavioral-therapy-for-insomnia-in-nurses-with-post-covid-19-condition-100517095",false,"NCT06013085","Effects of Cognitive-behavioral Therapy for Insomnia in Nurses With Post Covid-19 Condition","CBT-I","Inclusion Criteria:\n\n* nurses with post COVID-19 condition\n\nExclusion Criteria:\n\n* history of sleep apnea, narcolepsy, pregnant, seizure, with pacemaker",true,"ALL","20 Years","65 Years",{"count":47,"type":48},100,"ESTIMATED","INTERVENTIONAL",[51],"NA","Background: Neuropsychiatric conditions, such as insomnia, anxiety, depression, and pain are the most common symptoms experienced by nurses after acute infection of COVID-19. Although medication can assist nurses to improve these symptoms simultaneously in a short period of time, they are at risk of overuse of benzodiazepine hypnotics. Previous research supports the usefulness of cognitive behavioral therapy for insomnia (CBT-I) as self-management strategies in adults with insomnia, anxiety, depression, and pain. However, their effects on post COVID-19 condition have not been researched, and no previous head-to-head study compared the effects on these two approaches on insomnia and neuropsychiatric symptoms.\n\nAim: To investigate the effects of CBT-I on insomnia, anxiety, depression, and pain in nurses with post COVID-19 condition.\n\nMethods: In this two-arm, parallel randomized controlled trial, 100 participants will be 1:1 randomly assigned to one of two groups (CBT-I and control). The intervention phase will last 6 weeks, followed by a three-month follow-up. Primary outcomes are insomnia severity and sleep quality, whereas anxiety, depression, pain, and health-related quality of life are secondary outcomes. These variables will be assessed before and after the intervention, and at 1, 2, and 3 months after the end of the intervention. Additionally, discontinuing benzodiazepine hypnotics will be measured at 3 months after the end of the intervention.\n\nDiscussion: This study will provide evidence of the effects of CBT-I on improving insomnia, anxiety, depression, and pain among nurses with post COVID-19 condition. Results could also enhance means by which to discontinue benzodiazepine hypnotics.",[54],"Cognitive Behavioral Therapy","NOT_YET_RECRUITING","2023-08-25",{"date":58,"type":59},"2023-08-28","ACTUAL",{"date":61,"type":48},"2023-09-01",{"date":63,"type":48},"2026-07-31",{"name":5,"class":6}]